Wu, Jo-Hsuan http://orcid.org/0000-0002-9435-746X
Moghimi, Sasan
Nishida, Takashi
Mahmoudinezhad, Golnoush
Zangwill, Linda M.
Weinreb, Robert N. http://orcid.org/0000-0001-9553-3202
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY034148, R01EY011008, R01EY019869, R01EY027510, P30EY022589)
UC | UC San Francisco | Center for Tobacco Control Research and Education, University of California, San Francisco (T31IP1511)
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
Research to Prevent Blindness (Unrestricted Grant)
University of California Tobacco Related Disease Research Program
Article History
Received: 19 April 2023
Revised: 19 October 2023
Accepted: 26 October 2023
First Online: 11 November 2023
Competing interests
: SM reported grants from the National Eye Institute. TN is a consultant of Topcon. LZ reported grants from the National Eye Institute; grants from Heidelberg Engineering and nonfinancial support from Carl Zeiss Meditec, Optovue, Heidelberg Engineering, and Topcon. Consultant of Abbvie, AISight Health and Topcon and patents from Carl Zeiss Meditec. RNW is a consultant of Abbvie, Aerie Pharmaceuticals, Allergan, Amydis, Equinox, Eyenovia, Iantrek, IOPtic, Implandata, Nicox, and Topcon. RNW reported nonfinancial support from Heidelberg Engineering, Carl Zeiss Meditec, Konan Medical, Optovue, Centervue, and Topcon; grants from the National Eye Institute and National Institute of Minority Health Disparities, patents from Toromedes, Carl Zeiss Meditec to UCSD; all outside the submitted work. No other disclosures were reported.